Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.2044
-0.0255 (-11.09%)
Apr 1, 2026, 12:49 PM EDT - Market open

Cue Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
203067125123364
Market Cap Growth
-66.84%-56.21%-45.94%1.61%-66.32%-4.08%
Enterprise Value
-1.584.6645.9383.560.44304.96
Last Close Price
0.200.311.092.642.8511.31
PE Ratio
--1.09-1.51-2.38-1.91-8.02
PS Ratio
0.821.077.2622.7098.5324.38
PB Ratio
0.841.123.853.361.875.56
P/TBV Ratio
0.731.103.513.261.555.40
P/FCF Ratio
--1.35-1.85-3.12-2.92-9.16
P/OCF Ratio
--1.36-1.85-3.12-2.93-9.38
EV/Sales Ratio
-0.174.9515.2148.5420.41
EV/EBITDA Ratio
--0.18-1.12-1.62-1.16-7.18
EV/EBIT Ratio
--0.18-1.11-1.60-1.14-6.98
EV/FCF Ratio
--0.21-1.26-2.09-1.44-7.67
Debt / Equity Ratio
0.090.090.060.200.210.08
Debt / EBITDA Ratio
-0.16-0.16-0.22-0.28-0.37-0.24
Debt / FCF Ratio
-0.19-0.19-0.24-0.37-0.46-0.25
Net Debt / Equity Ratio
-0.87-0.87-0.78-0.91-0.87-0.83
Net Debt / EBITDA Ratio
0.900.900.330.661.091.28
Net Debt / FCF Ratio
1.051.050.370.851.361.37
Asset Turnover
0.740.740.200.070.010.16
Quick Ratio
2.562.561.712.946.615.28
Current Ratio
2.742.741.843.016.685.35
Return on Equity (ROE)
-121.11%-121.11%-149.03%-98.73%-80.82%-61.16%
Return on Assets (ROA)
-72.74%-72.74%-88.56%-68.25%-60.94%-48.33%
Return on Invested Capital (ROIC)
-400.36%-400.36%-884.96%-740.38%-518.55%-408.82%
Return on Capital Employed (ROCE)
-112.46%-112.46%-131.85%-83.99%-70.80%-56.83%
Earnings Yield
-118.48%-91.68%-66.06%-42.05%-52.28%-12.47%
FCF Yield
-97.38%-74.09%-54.01%-32.06%-34.22%-10.91%
Buyback Yield / Dilution
-68.18%-68.18%-23.11%-28.35%-13.95%-9.05%
Total Shareholder Return
-68.18%-68.18%-23.11%-28.35%-13.95%-9.05%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q